{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:04:45Z","timestamp":1793293485978,"version":"4.5.0"},"reference-count":127,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.prp.2025.156231","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T12:36:56Z","timestamp":1758026216000},"page":"156231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The role of WNT signaling in papillary thyroid cancer: Mechanisms, epigenetic regulation, therapeutic resistance, and emerging clinical strategies"],"prefix":"10.1016","volume":"275","author":[{"given":"Zhongqiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxia","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjuan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yacun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2025.156231_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S2213-8587(21)00027-9","article-title":"Thyroid cancer incidence trends by histology in 25 countries: a population-based study","volume":"9","author":"Miranda-Filho","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.prp.2025.156231_bib2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/thy.2023.0456","article-title":"Clinical outcomes of radioactive iodine redifferentiation therapy in previously iodine refractory differentiated thyroid cancers","volume":"34","author":"Toro-Tobon","year":"2024","journal-title":"Thyroid"},{"key":"10.1016\/j.prp.2025.156231_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.prp.2025.156231_bib4","article-title":"PROS1-MERTK axis drives tumor microenvironment crosstalk and progression in papillary thyroid microcarcinoma","author":"Zhang","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.prp.2025.156231_bib5","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.3390\/cancers16152686","article-title":"Unraveling cancer\u2019s wnt signaling: dynamic control through protein kinase regulation","volume":"16","author":"T\u00fcmen","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2025.156231_bib6","doi-asserted-by":"crossref","first-page":"99459","DOI":"10.3748\/wjg.v31.i9.99459","article-title":"Calculus bovis inhibits liver cancer via the Wnt\/\u03b2-catenin pathway","volume":"31","author":"Chen","year":"2025","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prp.2025.156231_bib7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3892\/ol.2024.14748","article-title":"Mechanism of APC truncation involved in colorectal cancer tumorigenesis","volume":"29","author":"Wang","year":"2024","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2025.156231_bib8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev-cellbio-120319-023657","article-title":"Cell biology of canonical wnt signaling","volume":"37","author":"Albrecht","year":"2021","journal-title":"Annu Rev. Cell Dev. Biol."},{"key":"10.1016\/j.prp.2025.156231_bib9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3390\/cancers15010259","article-title":"Integrative multi-OMICs identifies therapeutic response biomarkers and confirms fidelity of clinically annotated, serially passaged patient-derived xenografts established from primary and metastatic pediatric and AYA solid tumors","volume":"15","author":"Pandya","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2025.156231_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1243540","article-title":"Case report: papillary thyroid carcinoma in Goltz\u2013Gorlin syndrome","volume":"14","author":"Costanza","year":"2023","journal-title":"Front Endocrinol."},{"key":"10.1016\/j.prp.2025.156231_bib11","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3390\/cells12081204","article-title":"The multifaceted role of WNT signaling in alzheimer\u2019s disease onset and age-related progression","volume":"12","author":"Kostes","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.prp.2025.156231_bib12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/ng1330","article-title":"Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer","volume":"36","author":"Suzuki","year":"2004","journal-title":"Nat. Genet"},{"key":"10.1016\/j.prp.2025.156231_bib13","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells promote radioresistance by preferential activation of the DNA damage response","volume":"444","author":"Bao","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.prp.2025.156231_bib14","doi-asserted-by":"crossref","first-page":"20224","DOI":"10.1073\/pnas.1314239110","article-title":"Targeting Wnt-driven cancer through the inhibition of porcupine by LGK974","volume":"110","author":"Liu","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.prp.2025.156231_bib15","article-title":"Identification of key functional gene signatures indicative of dedifferentiation in papillary thyroid cancer","volume":"11","author":"Xu","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.prp.2025.156231_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature14404","article-title":"Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity","volume":"523","author":"Spranger","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.prp.2025.156231_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154371","article-title":"Significance of miRNAs on the thyroid cancer progression and resistance to treatment with special attention to the role of cross-talk between signaling pathways","volume":"243","author":"Doghish","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2025.156231_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-020-00557-2","article-title":"Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression","volume":"18","author":"Liu","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.prp.2025.156231_bib19","article-title":"Macrophages, as a promising strategy to targeted treatment for colorectal cancer metastasis in tumor immune microenvironment","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.prp.2025.156231_bib20","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.3390\/cells8111380","article-title":"Wnt signaling in the regulation of immune cell and cancer therapeutics","volume":"8","author":"Haseeb","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.prp.2025.156231_bib21","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-23-0110","article-title":"Papillary thyroid cancer immune phenotypes via tumor-infiltrating lymphocyte spatial analysis","volume":"30","author":"Nam","year":"2023","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.prp.2025.156231_bib22","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1002\/cam4.4836","article-title":"A novel prognostic model for papillary thyroid cancer based on epithelial\u2013mesenchymal transition-related genes","volume":"11","author":"Liu","year":"2022","journal-title":"Cancer Med"},{"key":"10.1016\/j.prp.2025.156231_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123015","article-title":"Cancer stem cell markers: symphonic masters of chemoresistance and immune evasion","author":"Sarabia-S\u00e1nchez","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2025.156231_bib24","article-title":"The role of MAPK, notch and wnt signaling pathways in papillary thyroid cancer: evidence from a systematic review and meta-analyzing microarray datasets employing bioinformatics knowledge and literature","volume":"37","author":"Amjad","year":"2024","journal-title":"Biochem Biophys. Rep."},{"key":"10.1016\/j.prp.2025.156231_bib25","doi-asserted-by":"crossref","first-page":"5100","DOI":"10.1038\/s41598-020-61985-1","article-title":"Enhanced expression of cyclin D1 and C-myc, a prognostic factor and possible mechanism for recurrence of papillary thyroid carcinoma","volume":"10","author":"Sanjari","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2025.156231_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fendo.2012.00031","article-title":"Role of the wnt pathway in thyroid cancer","volume":"3","author":"Sastre-Perona","year":"2012","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.prp.2025.156231_bib27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1089\/thy.2014.0338","article-title":"Relevance of BRAFV600E mutation testing versus RAS point mutations and RET\/PTC rearrangements evaluation in the diagnosis of thyroid cancer","volume":"25","author":"Rossi","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.prp.2025.156231_bib28","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1158\/0008-5472.CAN-18-2757","article-title":"Wnt\/PCP signaling contribution to carcinoma collective cell migration and metastasis","volume":"79","author":"VanderVorst","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.prp.2025.156231_bib29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/jcp.30529","article-title":"TGF-\u03b2 signaling: a recap of SMAD-independent and SMAD-dependent pathways","volume":"237","author":"Aashaq","year":"2022","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.prp.2025.156231_bib30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41392-025-02142-w","article-title":"Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances","volume":"10","author":"Xue","year":"2025","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.prp.2025.156231_bib31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12943-025-02306-w","article-title":"Wnt signaling in cancer: from biomarkers to targeted therapies and clinical translation","volume":"24","author":"Tufail","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2025.156231_bib32","article-title":"The regulatory network of epithelial-mesenchymal transition-associated non-coding RNAs in thyroid cancer: molecular mechanisms, clinical implications, and therapeutic strategies","volume":"15","author":"Zhao","year":"2025","journal-title":"Front Oncol."},{"key":"10.1016\/j.prp.2025.156231_bib33","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/abbs\/gmr079","article-title":"Wnt\/Ca 2+ signaling pathway: a brief overview","volume":"43","author":"De","year":"2011","journal-title":"Acta Biochim Biophys. Sin."},{"key":"10.1016\/j.prp.2025.156231_bib34","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.3390\/ijms22041950","article-title":"Thyroid carcinoma: phenotypic features, underlying biology and potential relevance for targeting therapy","volume":"22","author":"Hu","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156231_bib35","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1186\/s12967-023-04434-7","article-title":"Long non-coding RNAs as the critical regulators of PI3K\/AKT, TGF-\u03b2, and MAPK signaling pathways during breast tumor progression","volume":"21","author":"Maharati","year":"2023","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.prp.2025.156231_bib36","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41419-020-02827-w","article-title":"Exosomal lncRNA DOCK9-AS2 derived from cancer stem cell-like cells activated Wnt\/\u03b2-catenin pathway to aggravate stemness, proliferation, migration, and invasion in papillary thyroid carcinoma","volume":"11","author":"Dai","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.prp.2025.156231_bib37","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3390\/cancers16050957","article-title":"miRNA on the battlefield of cancer: significance in cancer stem cells, WNT pathway, and treatment","volume":"16","author":"Bhagtaney","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2025.156231_bib38","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.3390\/cancers12082249","article-title":"The possible role of cancer stem cells in the resistance to kinase inhibitors of advanced thyroid cancer","volume":"12","author":"Gian\u00ec","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2025.156231_bib39","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41419-021-04116-6","article-title":"The metabolic flexibility of quiescent CSC: implications for chemotherapy resistance","volume":"12","author":"Chen","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.prp.2025.156231_bib40","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/cells14030178","article-title":"Wnt Pathway-Targeted therapy in gastrointestinal cancers: integrating benchside insights with bedside applications","volume":"14","author":"Nayak","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.prp.2025.156231_bib41","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12943-022-01616-7","article-title":"Wnt signaling in colorectal cancer: pathogenic role and therapeutic target","volume":"21","author":"Zhao","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2025.156231_bib42","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3389\/fendo.2019.00523","article-title":"Immunohistochemical analysis of cancer stem cell marker expression in papillary thyroid cancer","volume":"10","author":"Kim","year":"2019","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.prp.2025.156231_bib43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.gendis.2015.12.004","article-title":"Wnt\/\u03b2-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance","volume":"3","author":"Mohammed","year":"2016","journal-title":"Genes Dis."},{"key":"10.1016\/j.prp.2025.156231_bib44","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3892\/or.2017.5777","article-title":"WNT10A\/\u03b2-catenin pathway in tumorigenesis of papillary thyroid carcinoma","volume":"38","author":"Dong","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.prp.2025.156231_bib45","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3390\/ijms22020504","article-title":"CHD4 predicts aggressiveness in PTC patients and promotes cancer stemness and EMT in PTC cells","volume":"22","author":"Pratheeshkumar","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156231_bib46","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3390\/cells14070538","article-title":"Stem cells in cancer: from mechanisms to therapeutic strategies","volume":"14","author":"Haddadin","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.prp.2025.156231_bib47","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41388-023-02889-y","article-title":"Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids","volume":"43","author":"Lasolle","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2025.156231_bib48","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-24-0319","article-title":"Enhancing radioactive iodine (RAI) incorporation in RAI-refractory differentiated thyroid cancer: current insights","volume":"14","author":"Hiromasa","year":"2025","journal-title":"Eur. Thyroid J."},{"key":"10.1016\/j.prp.2025.156231_bib49","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.7150\/thno.66142","article-title":"KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt\/\u03b2-catenin signaling pathway","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.prp.2025.156231_bib50","doi-asserted-by":"crossref","first-page":"113","DOI":"10.14715\/cmb\/2023.69.9.16","article-title":"Effect of silencing CITED1 gene to regulate PI3K\/AKT pathway on the biological function of PTC cells and its mechanism","volume":"69","author":"Chen","year":"2023","journal-title":"Cell Mol. Biol."},{"key":"10.1016\/j.prp.2025.156231_bib51","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s13238-020-00766-y","article-title":"KIF2C: a novel link between Wnt\/\u03b2-catenin and mTORC1 signaling in the pathogenesis of hepatocellular carcinoma","volume":"12","author":"Wei","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.prp.2025.156231_bib52","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1158\/0008-5472.CAN-08-1982","article-title":"The \u03b2-catenin axis integrates multiple signals downstream from RET\/papillary thyroid carcinoma leading to cell proliferation","volume":"69","author":"Castellone","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.prp.2025.156231_bib53","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1177\/09603271211023792","article-title":"Taraxasterol inhibits TGF-\u03b21-induced epithelial-to-mesenchymal transition in papillary thyroid cancer cells through regulating the Wnt\/\u03b2-catenin signaling","volume":"40","author":"Zhu","year":"2021","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.prp.2025.156231_bib54","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3803\/EnM.2023.1802","article-title":"Metabolic reprogramming in thyroid cancer","volume":"39","author":"Ju","year":"2024","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156231_bib55","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s12957-022-02815-8","article-title":"HIF-1\u03b1 and Caspase-3 expression in aggressive papillary thyroid carcinoma","volume":"20","author":"Zhang","year":"2022","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.prp.2025.156231_bib56","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3390\/cancers13081973","article-title":"Interplay between metabolism reprogramming and epithelial-to-mesenchymal transition in cancer stem cells","volume":"13","author":"Daniel","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2025.156231_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1431423","article-title":"Evaluation of the effect of GSK-3\u03b2 on liver cancer based on the PI3K\/AKT pathway","volume":"12","author":"Guo","year":"2024","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.prp.2025.156231_bib58","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12967-022-03260-7","article-title":"BRAF-activated WT1 contributes to cancer growth and regulates autophagy and apoptosis in papillary thyroid carcinoma","volume":"20","author":"Chen","year":"2022","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.prp.2025.156231_bib59","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1158\/1078-0432.CCR-21-0874","article-title":"Oncogenic mutations in PI3K\/AKT\/mTOR pathway effectors associate with worse prognosis in BRAFV600E-driven papillary thyroid cancer patients","volume":"27","author":"Pappa","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2025.156231_bib60","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13578-022-00934-z","article-title":"Aurora kinase a promotes the progression of papillary thyroid carcinoma by activating the mTORC2-AKT signalling pathway","volume":"12","author":"Zhao","year":"2022","journal-title":"Cell Biosci."},{"key":"10.1016\/j.prp.2025.156231_bib61","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3390\/ijms23020699","article-title":"Effects of anti-cancer drug sensitivity-related genetic differences on therapeutic approaches in refractory papillary thyroid cancer","volume":"23","author":"Yun","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156231_bib62","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3390\/biom12030453","article-title":"Cross-talk between p53 and wnt signaling in cancer","volume":"12","author":"Xiao","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.prp.2025.156231_bib63","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s12079-023-00793-4","article-title":"Mutant p53 gain-of-function stimulates canonical wnt signaling via PI3K\/AKT pathway in colon cancer","volume":"17","author":"Alvarado-Ortiz","year":"2023","journal-title":"J. Cell Commun. Signal"},{"key":"10.1016\/j.prp.2025.156231_bib64","first-page":"155","article-title":"Notch signaling in thyroid cancer","author":"Guenter","year":"2020","journal-title":"Notch Signaling Embryology Cancer Notch Signaling Cancer"},{"key":"10.1016\/j.prp.2025.156231_bib65","article-title":"Overexpression of NOTCH-regulated ankyrin repeat protein is associated with papillary thyroid carcinoma progression","volume":"12","author":"Zhang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2025.156231_bib66","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s00018-023-05098-8","article-title":"Targeting the NF-\u03baB pathway as a potential regulator of immune checkpoints in cancer immunotherapy","volume":"81","author":"Ebrahimi","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.prp.2025.156231_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.584626","article-title":"Regulation of PD-L1 expression by NF-\u03baB in cancer","volume":"11","author":"Antonangeli","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.prp.2025.156231_bib68","doi-asserted-by":"crossref","first-page":"16084","DOI":"10.18632\/oncotarget.14306","article-title":"The hippo signaling pathway provides novel anti-cancer drug targets","volume":"8","author":"Bae","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2025.156231_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2013.12","article-title":"RAF kinase inhibitor-independent constitutive activation of Yes-associated protein 1 promotes tumor progression in thyroid cancer","volume":"2","author":"Lee","year":"2013","journal-title":"Oncogenesis"},{"key":"10.1016\/j.prp.2025.156231_bib70","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41420-024-02157-2","article-title":"High aggressiveness of papillary thyroid cancer: from clinical evidence to regulatory cellular networks","volume":"10","author":"Zhang","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.prp.2025.156231_bib71","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s13287-022-02904-1","article-title":"Characteristics of the cancer stem cell niche and therapeutic strategies","volume":"13","author":"Ju","year":"2022","journal-title":"Stem Cell Res Ther."},{"key":"10.1016\/j.prp.2025.156231_bib72","first-page":"1","article-title":"Multifaceted roles of OCT4 in tumor microenvironment: biology and therapeutic implications","author":"Chen","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2025.156231_bib73","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4103\/jomfp.jomfp_166_21","article-title":"Immunohistochemical expression of putative cancer stem cell markers aldehyde dehydrogenase 1, SOX2, CD44 and OCT4 in different grades of oral epithelial dysplasia","volume":"26","author":"Thankappan","year":"2022","journal-title":"J. Oral. Maxillofac. Pathol."},{"key":"10.1016\/j.prp.2025.156231_bib74","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3892\/ol.2022.13622","article-title":"Proteomic analysis of radioiodine-refractory differentiated thyroid cancer identifies CHI3L1 upregulation in association with dysfunction of the sodium-iodine symporter","volume":"25","author":"Li","year":"2022","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2025.156231_bib75","article-title":"Role of sodium\/iodide symporter overexpression in inhibiting thyroid cancer cell invasion and stem cell maintenance by inhibiting the \u03b2-catenin\/LEF-1 pathway","volume":"10","author":"Luo","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.prp.2025.156231_bib76","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3389\/fendo.2020.00566","article-title":"Cancer stem cells in thyroid tumors: from the origin to metastasis","volume":"11","author":"Veschi","year":"2020","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.prp.2025.156231_bib77","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.humpath.2017.03.012","article-title":"Expression of MRP1 and ABCG2 is associated with adverse clinical outcomes of papillary thyroid carcinoma with a solid component","volume":"67","author":"Ohashi","year":"2017","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2025.156231_bib78","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","article-title":"PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.prp.2025.156231_bib79","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.biochi.2023.03.001","article-title":"Wnt\/\u03b2-catenin signaling pathway-a versatile player in apoptosis and autophagy","volume":"211","author":"Ma","year":"2023","journal-title":"Biochimie"},{"key":"10.1016\/j.prp.2025.156231_bib80","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1042\/EBC20220016","article-title":"WNT signaling and cancer stemness","volume":"66","author":"Katoh","year":"2022","journal-title":"Essays Biochem"},{"key":"10.1016\/j.prp.2025.156231_bib81","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02824-21","article-title":"Wnt-\u03b2-catenin signaling in human dendritic cells mediates regulatory T-cell responses to fungi via the PD-L1 pathway","volume":"12","author":"Karnam","year":"2021","journal-title":"MBio"},{"key":"10.1016\/j.prp.2025.156231_bib82","first-page":"185","article-title":"Overview of Wnt\/\u03b2-Catenin pathway and DNA Damage\/Repair in cancer","volume":"14","author":"Nadin","year":"2025","journal-title":"Bioogy"},{"key":"10.1016\/j.prp.2025.156231_bib83","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013349","article-title":"WNT inhibition creates a BRCA-like state in Wnt-addicted cancer","volume":"13","author":"Kaur","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.prp.2025.156231_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1390300","article-title":"DNA damage response-related ncRNAs as regulators of therapy resistance in cancer","volume":"15","author":"Gao","year":"2024","journal-title":"Front Pharm."},{"key":"10.1016\/j.prp.2025.156231_bib85","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12957-024-03568-2","article-title":"The role of epigenetic methylations in thyroid cancer","volume":"22","author":"Yu","year":"2024","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.prp.2025.156231_bib86","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1089\/thy.2024.0303","article-title":"DNA methylation dynamics and prognostic implications in metastatic differentiated thyroid cancer","volume":"35","author":"Rodr\u00edguez-Lloveras","year":"2025","journal-title":"Thyroid"},{"key":"10.1016\/j.prp.2025.156231_bib87","doi-asserted-by":"crossref","first-page":"664","DOI":"10.21037\/atm-21-505","article-title":"LncRNA ABCC6P1 promotes proliferation and migration of papillary thyroid cancer cells via Wnt\/\u03b2-catenin signaling pathway","volume":"9","author":"Guan","year":"2021","journal-title":"Ann. Transl. Med"},{"key":"10.1016\/j.prp.2025.156231_bib88","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00280-021-04270-w","article-title":"Upregulation of TRIB2 by Wnt\/\u03b2-catenin activation in BRAF V600E papillary thyroid carcinoma cells confers resistance to BRAF inhibitor vemurafenib","volume":"88","author":"Wang","year":"2021","journal-title":"Cancer Chemother. Pharm."},{"key":"10.1016\/j.prp.2025.156231_bib89","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bbrc.2023.03.033","article-title":"Novel LncRNA AK023507 inhibits cell metastasis and proliferation in papillary thyroid cancer through \u03b2-catenin\/Wnt signaling pathway","volume":"655","author":"Yang","year":"2023","journal-title":"Biochem Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2025.156231_bib90","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1080\/21655979.2021.1935404","article-title":"ETS like-1 protein ELK1-induced lncRNA LINC01638 accelerates the progression of papillary thyroid cancer by regulating Axin2 through Wnt\/\u03b2-catenin signaling pathway","volume":"12","author":"Lv","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.prp.2025.156231_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2025.102902","article-title":"METTL3-mediated m6A modification of MT1G inhibits papillary thyroid carcinoma cell growth and metastasis via Wnt\/\u03b2-catenin pathway","volume":"95","author":"Liu","year":"2025","journal-title":"Tissue Cell"},{"key":"10.1016\/j.prp.2025.156231_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.755097","article-title":"MicroRNAs in papillary thyroid cancer: what is new in diagnosis and treatment","volume":"11","author":"Papaioannou","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.prp.2025.156231_bib93","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.3892\/or.2017.5994","article-title":"miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma","volume":"38","author":"Qiu","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.prp.2025.156231_bib94","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jss.2014.02.012","article-title":"MicroRNA-21 regulates biological behaviors in papillary thyroid carcinoma by targeting programmed cell death 4","volume":"189","author":"Zhang","year":"2014","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.prp.2025.156231_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2021.101647","article-title":"MiR-200c promotes papillary thyroid cancer cell proliferation, migration, and invasion by downregulating PTEN","volume":"73","author":"Guo","year":"2021","journal-title":"Tissue Cell"},{"key":"10.1016\/j.prp.2025.156231_bib96","doi-asserted-by":"crossref","first-page":"11795","DOI":"10.1080\/21655979.2021.2008639","article-title":"Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt\/\u03b2-catenin signaling pathway and modulating the ratio of microRNA-195 (miR-195) to vascular endothelial growth factor a (VEGFA) expression","volume":"12","author":"Zeng","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.prp.2025.156231_bib97","first-page":"594","article-title":"MicroRNA-506 as a tumor suppressor in anaplastic thyroid carcinoma by regulation of WNT and NOTCH signaling pathways","volume":"26","author":"Navaei","year":"2023","journal-title":"Iran. J. Basic Med Sci."},{"key":"10.1016\/j.prp.2025.156231_bib98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-021-02097-2","article-title":"Long noncoding RNA FER1L4 promotes the malignant processes of papillary thyroid cancer by targeting the miR-612\/Cadherin 4 axis","volume":"21","author":"Wu","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.prp.2025.156231_bib99","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12967-024-05012-1","article-title":"Cytosolic cadherin 4 promotes angiogenesis and metastasis in papillary thyroid cancer by suppressing the ubiquitination\/degradation of \u03b2-catenin","volume":"22","author":"Wu","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.prp.2025.156231_bib100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bbrc.2021.01.109","article-title":"LncRNA FAM230B promotes the metastasis of papillary thyroid cancer by sponging the miR-378a-3p\/WNT5A axis","volume":"546","author":"Zhou","year":"2021","journal-title":"Biochem Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2025.156231_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153561","article-title":"LncRNA CASC15 promotes the proliferation of papillary thyroid carcinoma cells by regulating the miR-7151\u20135p\/WNT7A axis","volume":"225","author":"Bai","year":"2021","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2025.156231_bib102","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s12935-022-02817-2","article-title":"LncRNA HOTAIR impairs the prognosis of papillary thyroid cancer via regulating cellular malignancy and epigenetically suppressing DLX1","volume":"22","author":"Kuo","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.prp.2025.156231_bib103","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1007\/s40618-024-02388-1","article-title":"HYPOXIA induces lncRNA HOTAIR for recruiting RELA in papillary thyroid cancer cells to upregulate miR-181a and promote angiogenesis","volume":"47","author":"Lu","year":"2024","journal-title":"J. Endocrinol. Invest"},{"key":"10.1016\/j.prp.2025.156231_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-5533-4","article-title":"LncRNA ENST00000539653 acts as an oncogenic factor via MAPK signalling in papillary thyroid cancer","volume":"19","author":"Song","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2025.156231_bib105","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s00432-017-2414-6","article-title":"ZCCHC12, a novel oncogene in papillary thyroid cancer","volume":"143","author":"Wang","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.prp.2025.156231_bib106","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1158\/2326-6066.CIR-23-1047","article-title":"CD36+ proinflammatory macrophages interact with ZCCHC12+ tumor cells in papillary thyroid cancer promoting tumor progression and recurrence","volume":"12","author":"Zhang","year":"2024","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.prp.2025.156231_bib107","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41420-021-00798-1","article-title":"CircRNA circTIAM1 promotes papillary thyroid cancer progression through the miR-646\/HNRNPA1 signaling pathway","volume":"8","author":"Zhang","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.prp.2025.156231_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.640460","article-title":"Translational potential of Epigenetic-Based markers on Fine-Needle aspiration thyroid specimens","volume":"8","author":"Canberk","year":"2021","journal-title":"Front Med."},{"key":"10.1016\/j.prp.2025.156231_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154495","article-title":"Inflammatory tumor microenvironment of thyroid cancer promotes cellular dedifferentiation and silencing of iodide-handling genes expression","volume":"246","author":"Zhang","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2025.156231_bib110","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1210\/clinem\/dgac664","article-title":"DNA methylation in autoimmune thyroid disease","volume":"108","author":"Lafontaine","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156231_bib111","doi-asserted-by":"crossref","first-page":"10982","DOI":"10.3390\/ijms252010982","article-title":"Acetylation of histone H3 in cancer progression and prognosis","volume":"25","author":"Miziak","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156231_bib112","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/hed.27377","article-title":"Correlation of DNA methylation and lymph node metastasis in papillary thyroid carcinoma","volume":"45","author":"Zhao","year":"2023","journal-title":"Head. Neck"},{"key":"10.1016\/j.prp.2025.156231_bib113","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41420-021-00614-w","article-title":"Loss of ID3 drives papillary thyroid cancer metastasis by targeting E47-mediated epithelial to mesenchymal transition","volume":"7","author":"Xu","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.prp.2025.156231_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154385","article-title":"The expression of HDAC9 and P300 in papillary thyroid carcinoma cell line","volume":"243","author":"Ozisik","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2025.156231_bib115","first-page":"1","article-title":"Epigenomic profiling of papillary thyroid carcinoma reveals distinct subtypes with clinical implications","volume":"9","author":"Lee","year":"2025","journal-title":"NPJ Precis Oncol."},{"key":"10.1016\/j.prp.2025.156231_bib116","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41416-020-0916-5","article-title":"First-in-human study of the PARP\/tankyrase inhibitor E7449 in patients with advanced solid tumours and evaluation of a novel drug-response predictor","volume":"123","author":"Plummer","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2025.156231_bib117","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1089\/thy.2012.0388","article-title":"5-aza-2\u2032-deoxycytidine has minor effects on differentiation in human thyroid cancer cell lines, but modulates genes that are involved in adaptation in vitro","volume":"23","author":"Dom","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.prp.2025.156231_bib118","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3390\/cells9030589","article-title":"Small molecule wnt pathway modulators from natural sources: history, state of the art and perspectives","volume":"9","author":"Blagodatski","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.prp.2025.156231_bib119","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41416-021-01389-8","article-title":"Phase 1 study of single-agent WNT974, a first-in-class porcupine inhibitor, in patients with advanced solid tumours","volume":"125","author":"Rodon","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2025.156231_bib120","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/oncolo\/oyad007","article-title":"A phase Ib\/II study of WNT974+ encorafenib+ cetuximab in patients with BRAF V600E-mutant KRAS wild-type metastatic colorectal cancer","volume":"28","author":"Tabernero","year":"2023","journal-title":"Oncologist"},{"key":"10.1016\/j.prp.2025.156231_bib121","doi-asserted-by":"crossref","first-page":"T179","DOI":"10.1530\/ERC-21-0024","article-title":"Redifferentiation-facilitated radioiodine therapy in thyroid cancer","volume":"28","author":"Lamartina","year":"2021","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.prp.2025.156231_bib122","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.12659\/MSM.906020","article-title":"Combined treatment with valproic acid and 5-aza-2\u2032-deoxycytidine synergistically inhibits human clear cell renal cell carcinoma growth and migration","volume":"24","author":"Xi","year":"2018","journal-title":"Med Sci. Monit."},{"key":"10.1016\/j.prp.2025.156231_bib123","article-title":"Towards an era of precise diagnosis and treatment: role of novel molecular modification-based imaging and therapy for dedifferentiated thyroid cancer","volume":"13","author":"Li","year":"2022","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.prp.2025.156231_bib124","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41418-023-01213-1","article-title":"Mapping epigenetic modifications by sequencing technologies","volume":"32","author":"Chen","year":"2025","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.prp.2025.156231_bib125","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.5c00473","article-title":"Translational insights into Stimuli-Responsive magnetic nanoparticles for breast cancer treatment","author":"Khan","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.prp.2025.156231_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125721","article-title":"Harnessing MUC1 aptamer-targeted nanoparticles for precision Medicine in breast cancer","author":"Khan","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.prp.2025.156231_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123276","article-title":"Advancements in dextran-based nanocarriers for treatment and imaging of breast cancer","volume":"643","author":"Khan","year":"2023","journal-title":"Int. J. Pharm."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825004248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825004248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T04:41:55Z","timestamp":1760503315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825004248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":127,"alternative-id":["S0344033825004248"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.156231","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of WNT signaling in papillary thyroid cancer: Mechanisms, epigenetic regulation, therapeutic resistance, and emerging clinical strategies","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.156231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156231"}}